Aplisens S.A. Logo

Aplisens S.A.

APN.WA

(4.0)
Stock Price

21,20 PLN

13.94% ROA

14.88% ROE

8.79x PER

Market Cap.

256.194.900,00 PLN

0% DER

3.42% Yield

17.38% NPM

Aplisens S.A. Stock Analysis

Aplisens S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aplisens S.A. Fundamental Stock Analysis
# Analysis Rating
1 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

2 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

3 Net Profit Growth

The net profit of this company has steadily increased over the last five years, showcasing a favorable financial performance and making it an enticing option for investors seeking growth potential.

4 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

5 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

6 ROE

ROE in an average range (14.06%) suggests satisfactory profitability and decent utilization of shareholders' equity.

7 PBV

The stock's PBV ratio (1.24x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

8 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

9 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

10 Dividend Growth

The company's dividend growth has shown a positive trajectory over the past three years, consistently increasing year after year, indicating a favorable trend for potential investors.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (173), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

Aplisens S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aplisens S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Aplisens S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aplisens S.A. Revenue
Year Revenue Growth
2008 45.163.000
2009 45.158.000 -0.01%
2010 46.767.000 3.44%
2011 69.311.000 32.53%
2012 82.049.000 15.52%
2013 80.103.000 -2.43%
2014 89.322.000 10.32%
2015 88.365.000 -1.08%
2016 94.295.000 6.29%
2017 99.845.000 5.56%
2018 105.713.000 5.55%
2019 118.512.000 10.8%
2020 107.993.000 -9.74%
2021 121.404.000 11.05%
2022 147.827.000 17.87%
2023 182.520.000 19.01%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aplisens S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aplisens S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 8.926.000
2009 10.555.000 15.43%
2010 9.338.000 -13.03%
2011 12.728.000 26.63%
2012 12.879.000 1.17%
2013 13.421.000 4.04%
2014 12.400.000 -8.23%
2015 13.157.000 5.75%
2016 13.848.000 4.99%
2017 15.278.000 9.36%
2018 16.752.000 8.8%
2019 17.273.000 3.02%
2020 17.474.000 1.15%
2021 18.650.000 6.31%
2022 21.541.000 13.42%
2023 20.888.000 -3.13%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aplisens S.A. EBITDA
Year EBITDA Growth
2008 12.593.000
2009 11.063.000 -13.83%
2010 14.189.000 22.03%
2011 16.367.000 13.31%
2012 18.063.000 9.39%
2013 22.211.000 18.68%
2014 22.037.000 -0.79%
2015 22.603.000 2.5%
2016 21.613.000 -4.58%
2017 23.053.000 6.25%
2018 24.633.000 6.41%
2019 25.725.000 4.24%
2020 17.541.000 -46.66%
2021 28.996.000 39.51%
2022 33.460.000 13.34%
2023 57.560.000 41.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aplisens S.A. Gross Profit
Year Gross Profit Growth
2008 20.069.000
2009 20.335.000 1.31%
2010 21.295.000 4.51%
2011 30.504.000 30.19%
2012 33.037.000 7.67%
2013 31.607.000 -4.52%
2014 32.342.000 2.27%
2015 32.577.000 0.72%
2016 31.842.000 -2.31%
2017 34.917.000 8.81%
2018 37.314.000 6.42%
2019 38.468.000 3%
2020 35.436.000 -8.56%
2021 43.786.000 19.07%
2022 58.774.000 25.5%
2023 76.376.000 23.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aplisens S.A. Net Profit
Year Net Profit Growth
2008 8.529.000
2009 7.005.000 -21.76%
2010 9.773.000 28.32%
2011 12.010.000 18.63%
2012 14.695.000 18.27%
2013 14.470.000 -1.55%
2014 12.629.000 -14.58%
2015 13.710.000 7.88%
2016 14.100.000 2.77%
2017 19.648.000 28.24%
2018 14.327.000 -37.14%
2019 14.104.000 -1.58%
2020 14.452.000 2.41%
2021 17.204.000 16%
2022 20.441.000 15.84%
2023 42.020.000 51.35%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aplisens S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 1
2009 1 0%
2010 1 0%
2011 1 0%
2012 1 100%
2013 1 0%
2014 1 0%
2015 1 100%
2016 1 0%
2017 2 0%
2018 1 0%
2019 1 0%
2020 1 0%
2021 2 0%
2022 2 0%
2023 7 83.33%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aplisens S.A. Free Cashflow
Year Free Cashflow Growth
2008 -2.574.000
2009 3.554.000 172.43%
2010 1.933.000 -83.86%
2011 6.057.000 68.09%
2012 5.601.000 -8.14%
2013 -9.543.000 158.69%
2014 1.579.000 704.37%
2015 9.729.000 83.77%
2016 11.000.000 11.55%
2017 7.541.000 -45.87%
2018 10.495.000 28.15%
2019 17.449.000 39.85%
2020 25.296.000 31.02%
2021 15.110.000 -67.41%
2022 12.423.000 -21.63%
2023 6.028.000 -106.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aplisens S.A. Operating Cashflow
Year Operating Cashflow Growth
2008 6.160.000
2009 5.469.000 -12.63%
2010 9.363.000 41.59%
2011 12.906.000 27.45%
2012 16.371.000 21.17%
2013 15.113.000 -8.32%
2014 14.649.000 -3.17%
2015 15.573.000 5.93%
2016 20.602.000 24.41%
2017 16.177.000 -27.35%
2018 23.170.000 30.18%
2019 26.287.000 11.86%
2020 25.296.000 -3.92%
2021 20.910.000 -20.98%
2022 22.059.000 5.21%
2023 9.427.000 -134%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aplisens S.A. Capital Expenditure
Year Capital Expenditure Growth
2008 8.734.000
2009 1.915.000 -356.08%
2010 7.430.000 74.23%
2011 6.849.000 -8.48%
2012 10.770.000 36.41%
2013 24.656.000 56.32%
2014 13.070.000 -88.65%
2015 5.844.000 -123.65%
2016 9.602.000 39.14%
2017 8.636.000 -11.19%
2018 12.675.000 31.87%
2019 8.838.000 -43.41%
2020 0 0%
2021 5.800.000 100%
2022 9.636.000 39.81%
2023 3.399.000 -183.5%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aplisens S.A. Equity
Year Equity Growth
2008 48.498.000
2009 69.283.000 30%
2010 79.096.000 12.41%
2011 94.012.000 15.87%
2012 106.601.000 11.81%
2013 119.491.000 10.79%
2014 119.065.000 -0.36%
2015 130.446.000 8.72%
2016 143.335.000 8.99%
2017 148.860.000 3.71%
2018 160.601.000 7.31%
2019 163.624.000 1.85%
2020 173.256.000 5.56%
2021 180.741.000 4.14%
2022 186.180.000 2.92%
2023 208.971.000 10.91%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aplisens S.A. Assets
Year Assets Growth
2008 58.955.000
2009 74.764.000 21.15%
2010 82.369.000 9.23%
2011 106.532.000 22.68%
2012 121.725.000 12.48%
2013 135.754.000 10.33%
2014 130.925.000 -3.69%
2015 139.231.000 5.97%
2016 155.565.000 10.5%
2017 160.711.000 3.2%
2018 174.457.000 7.88%
2019 175.439.000 0.56%
2020 182.680.000 3.96%
2021 192.602.000 5.15%
2022 202.411.000 4.85%
2023 230.849.000 12.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aplisens S.A. Liabilities
Year Liabilities Growth
2008 10.025.000
2009 5.157.000 -94.4%
2010 3.273.000 -57.56%
2011 12.083.000 72.91%
2012 14.426.000 16.24%
2013 15.518.000 7.04%
2014 11.200.000 -38.55%
2015 7.815.000 -43.31%
2016 10.712.000 27.04%
2017 10.047.000 -6.62%
2018 13.856.000 27.49%
2019 11.815.000 -17.27%
2020 9.424.000 -25.37%
2021 11.861.000 20.55%
2022 16.231.000 26.92%
2023 21.878.000 25.81%

Aplisens S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
15.32
Net Income per Share
2.66
Price to Earning Ratio
8.79x
Price To Sales Ratio
1.54x
POCF Ratio
7.9
PFCF Ratio
12.49
Price to Book Ratio
1.24
EV to Sales
1.47
EV Over EBITDA
5.49
EV to Operating CashFlow
7.62
EV to FreeCashFlow
11.92
Earnings Yield
0.11
FreeCashFlow Yield
0.08
Market Cap
0,26 Bil.
Enterprise Value
0,24 Bil.
Graham Number
33.59
Graham NetNet
2.97

Income Statement Metrics

Net Income per Share
2.66
Income Quality
0.85
ROE
0.15
Return On Assets
0.13
Return On Capital Employed
0.17
Net Income per EBT
0.76
EBT Per Ebit
1.05
Ebit per Revenue
0.22
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.12
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.42
Operating Profit Margin
0.22
Pretax Profit Margin
0.23
Net Profit Margin
0.17

Dividends

Dividend Yield
0.03
Dividend Yield %
3.42
Payout Ratio
0.31
Dividend Per Share
0.8

Operating Metrics

Operating Cashflow per Share
2.96
Free CashFlow per Share
1.89
Capex to Operating CashFlow
-0.36
Capex to Revenue
-0.07
Capex to Depreciation
-1.6
Return on Invested Capital
0.14
Return on Tangible Assets
0.14
Days Sales Outstanding
0
Days Payables Outstanding
57.36
Days of Inventory on Hand
257.15
Receivables Turnover
0
Payables Turnover
6.36
Inventory Turnover
1.42
Capex per Share
-1.07

Balance Sheet

Cash per Share
1,86
Book Value per Share
18,83
Tangible Book Value per Share
17.09
Shareholders Equity per Share
18.83
Interest Debt per Share
0.07
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
-0.26
Current Ratio
5.91
Tangible Asset Value
0,19 Bil.
Net Current Asset Value
0,10 Bil.
Invested Capital
0
Working Capital
0,10 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,00 Bil.
Average Payables
0,02 Bil.
Average Inventory
66937500
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aplisens S.A. Dividends
Year Dividends Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 1 0%
2023 1 0%

Aplisens S.A. Profile

About Aplisens S.A.

Aplisens S.A. manufactures and sells process instrumentation products in Poland and internationally. Its products are primarily focused on electronic pressure and differential pressure measurement technology. The company offers pressure transmitters, pressure gauges, and hart communication tools; hydrostatic level probes, level transmitters, and level switches; temperature transmitters, sensors, and displays; electromagnetic and nozzle flow meters; and electro pneumatic positioners and APIS mounting kits. It also provides flanged, chemical flanged, threaded, threaded chemical, and sanitary diaphragm seals; displays, digital indicators, linear indicators, data loggers, and multichannel controllers; valve manifolds and fitting accessories; power supplies, isolators/signal converters, and overvoltage protection circuits; and fuel level probes, fuel filler security products, fuel level converters, pulse converters, RFID rotation direction detectors and sensors, electronic seals, and fuel filler flap RFID tank door sensors for the automotive industry. The company was founded in 1992 and is headquartered in Warsaw, Poland.

CEO
Mr. Adam Zurawski
Employee
478
Address
Morelowa 7
Warsaw, 03-192

Aplisens S.A. Executives & BODs

Aplisens S.A. Executives & BODs
# Name Age
1 Mr. Adam Zurawski
President of the Management Board
70
2 Mr. Andrzej Kobialka
Head of Service Department & Secretary
70
3 Grzegorz Grochalski
Chief Accountant
70

Aplisens S.A. Competitors

Torpol S.A. Logo
Torpol S.A.

TOR.WA

(2.2)
Amica S.A. Logo
Amica S.A.

AMC.WA

(1.0)
Izostal S.A. Logo
Izostal S.A.

IZS.WA

(2.5)
Ciech S.A. Logo
Ciech S.A.

CIE.WA

(2.0)